Subcutaneous or intramuscular injections of insulin in children. Are we injecting where we think we are?

Diabetes Care. 1996 Dec;19(12):1434-6. doi: 10.2337/diacare.19.12.1434.

Abstract

Objective: This study was designed to assess the insulin injection location in a group of children who had their injection according to their daily practice, thought to lead to subcutaneous injections.

Research design and methods: The location of the insulin deposit at the injection site was visualized using an ultrasound device.

Results: The exact insulin injection location could be localized, and 18 of 59 injections (30.5%) (one injection for each child) were in the intramuscular tissue. Of the children who had intramuscular injection, 15 of 18 were boys. The children who had an intramuscular injection had a significantly lower percentile of BMI (mean +/- SE: 47 +/- 8 vs. 72 +/- 4, P = 0.004), lower distance from skin surface to muscle fascia without a skinfold (5.6 +/- 0.6 vs. 11 +/- 0.7 mm, P < 0.0001), and a lower distance from skin surface to muscle fascia with a skinfold (8.1 +/- 0.9 vs. 15.9 +/- 0.8 mm, P < 0.0001) than children who had a subcutaneous insulin injection.

Conclusions: We identified a group of children at risk for intramuscular insulin injections and that may deserve specific injection technique and advice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Body Mass Index
  • Child
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / therapeutic use
  • Injections, Intramuscular*
  • Injections, Subcutaneous*
  • Insulin / administration & dosage*
  • Insulin / therapeutic use
  • Male
  • Muscle, Skeletal / diagnostic imaging
  • Parents
  • Self Care
  • Skin / diagnostic imaging
  • Skinfold Thickness
  • Ultrasonography

Substances

  • Hypoglycemic Agents
  • Insulin